A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System

被引:2
|
作者
Holers, V. Michael [1 ]
La Rosa, Francisco G. [2 ]
Banda, Nirmal K. [1 ]
机构
[1] Univ Colorado, Sch Med, Div Rheumatol, Anschutz Med Campus,1775 Aurora Court, Aurora, CO 80045 USA
[2] Univ Colorado, Sch Med, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
Axial spondyloarthritis; Arthritis; Complement; ANTIBODY-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISEASE; HLA-B27; COLLAGEN; ACTIVATION; SERUM; MICE; SPONDYLITIS; DEFICIENCY;
D O I
10.4110/in.2021.21.e45
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many mouse models of rheumatoid arthritis have been identified, but only a limited number are present for axial spondyloarthritis (AxSpA). Collagen Ab-induced arthritis (CAIA) is one of the most widely used mouse models of arthritis, and it is complement-dependent. We found that mice developing CAIA also developed spinal lesions similar to those found in AxSpA. To induce CAIA, mice were injected intraperitoneally at day 0 with anti-collagen Abs, followed by LPS injection at day 3. CAIA mice demonstrated a significant kyphosis through the spine, as well as hypertrophic cartilage and osseous damage of the intravertebral joints. Immunohistochemical staining of the kyphotic area revealed increased complement C3 deposition and macrophage infiltration, with localization to the intravertebral joint margins. Near Infrared (NIR) in vivo imaging showed that anti-collagen Abs conjugated with IRDye (R) 800CW not only localized to cartilage surface in the joints but also to the spine in arthritic mice. We report here a novel preclinical mouse model in which, associated with the induction of CAIA, mice also exhibited salient features of AxSpA; this new experimental model of AxSpA may allow investigators to shed light on the local causal mechanisms of AxSpA bone and soft tissue changes as well as treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Inflammation, new bone formation and treatment options in axial spondyloarthritis
    Sieper, Joachim
    Poddubnyy, Denis
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) : 1439 - 1441
  • [22] Imaging of axial spondyloarthritis. New aspects and differential diagnoses
    Braun, J.
    Baraliakos, X.
    Buehring, B.
    Kiltz, U.
    Fruth, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : S35 - S42
  • [23] Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis
    Mease, Philip
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (07)
  • [24] A New Mouse Model to Explore Therapies for Preeclampsia
    Ahmed, Abdulwahab
    Singh, Jameel
    Khan, Ysodra
    Seshan, Surya V.
    Girardi, Guillermina
    PLOS ONE, 2010, 5 (10):
  • [25] Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals
    Korkosz, Mariusz
    Czepiel, Marcin
    Gula, Zofia
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Rutkowska-Zapala, Magdalena
    Gruca, Anna
    Lenart, Marzena
    Baran, Jaroslaw
    Gasowski, Jerzy
    Blyszczuk, Przemyslaw
    Siedlar, Maciej
    BMC MUSCULOSKELETAL DISORDERS, 2018, 19
  • [26] Measuring Spinal Mobility Using an Inertial Measurement Unit System: A Reliability Study in Axial Spondyloarthritis
    O'Grady, Megan
    O'Dwyer, Tom
    Connolly, James
    Condell, Joan
    Esquivel, Karla Munoz
    O'Shea, Finbar D.
    Gardiner, Philip
    Wilson, Fiona
    DIAGNOSTICS, 2021, 11 (03)
  • [27] Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
    Ferraz-Amaro, Ivan
    Rueda-Gotor, Javier
    Genre, Fernanda
    Corrales, Alfonso
    Blanco, Ricardo
    Portilla, Virginia
    Gonzalez Mazon, Inigo
    Llorca, Javier
    Exposito, Rosa
    Vicente, Esther F.
    Carlos Quevedo-Abeledo, Juan
    Rodriguez-Lozano, Carlos
    Ortega-Castro, Rafaela
    Lourdes Ladehesa-Pineda, Maria
    Fernandez-Carballido, Cristina
    Paz Martinez-Vidal, M.
    Castro-Corredor, David
    Anino-Fernandez, Joaquin
    Garcia Vivar, Maria Luz
    Galindez-Agirregoikoa, Eva
    Peiteado, Diana
    Plasencia-Rodriguez, Chamaida
    Montes Perez, Esther
    Diaz, Carlos Fernandez
    Castaneda, Santos
    Angel Gonzalez-Gay, Miguel
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [28] The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand
    White, Douglas
    Lao, Chunhuan
    Williams, Megan
    Lawrenson, Ross
    Dalbeth, Nicola
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1505) : 38 - 47
  • [29] New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice
    Dubash, Sayam
    McGonagle, Dennis
    Marzo-Ortega, Helena
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (03) : 77 - 87
  • [30] The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand
    White, Douglas
    Lao, Chunhuan
    Williams, Megan
    Lawrenson, Ross
    Dalbeth, Nicola
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1506) : 10 - 19